Directory
>
Debie Hoivik
Debie Hoivik
Vice President, Early Development | Akebia Therapeutics
Cambridge, Massachusetts, United States
Debie Hoivik
Summary
Debie Hoivik is a seasoned professional with over 20 years of experience in the pharmaceutical and medicine manufacturing industry, specializing in nonclinical drug safety and translational medicine. Currently serving as Vice President of Early Development at Akebia Therapeutics, Debie has a robust background in analytical chemistry, biochemistry, and pharmacology. Her career includes significant roles at prestigious companies such as Boehringer Ingelheim and GlaxoSmithKline, where she contributed to the development of new chemical entities and biosimilars. Debie is known for her leadership in cross-functional teams and her commitment to improving patient outcomes, particularly in the area of kidney disease. With a Ph.D. in Pharmacology and Toxicology from The University of Connecticut, she combines scientific expertise with strategic project management skills. Debie's passion for advancing drug safety protocols and her extensive network within the industry make her a valuable asset in the pharmaceutical landscape.
Debie Hoivik
Work Experience
Vice President, Early Development at
Akebia Therapeutics
February 2022 - Present
Senior Director, Nonclinical Drug Safety at
Akebia Therapeutics
May 2019 - February 2022
Nonclinical Drug Safety and Development at
Boehringer Ingelheim
September 2005 - May 2019
Medicine Safety Evaluation at
GSK
January 1998 - January 2005
Debie Hoivik
Education
University of Connecticut, Doctor Of Philosophy (Ph.D.)
Texas A&M University, Post-Doc
Frequently Asked Questions about Debie Hoivik
What is Debie Hoivik email address?
Debie Hoivik's primary email address is ************@akebia.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Debie Hoivik work for?
Debie Hoivik is a Vice President, Early Development at Akebia Therapeutics, a company specializing in Commercial physical research.
Where Debie Hoivik graduated from?
Debie Hoivik holds a degree in Pharmacology And Toxicology from University of Connecticut.
How can I directly contact Debie Hoivik?
To contact Debie Hoivik directly, you can use the email address ************@akebia.com. Complete contact information is available upon registration with Muraena.
Who is Debie Hoivik?
Debie Hoivik is a seasoned professional with over 20 years of experience in the pharmaceutical and medicine manufacturing industry, specializing in nonclinical drug safety and translational medicine. Currently serving as Vice President of Early Development at Akebia Therapeutics, Debie has a robust background in analytical chemistry, biochemistry, and pharmacology. Her career includes significant roles at prestigious companies such as Boehringer Ingelheim and GlaxoSmithKline, where she contributed to the development of new chemical entities and biosimilars. Debie is known for her leadership in cross-functional teams and her commitment to improving patient outcomes, particularly in the area of kidney disease. With a Ph.D. in Pharmacology and Toxicology from The University of Connecticut, she combines scientific expertise with strategic project management skills. Debie's passion for advancing drug safety protocols and her extensive network within the industry make her a valuable asset in the pharmaceutical landscape.
Debie`s contact details
************@akebia.com
************@boehringer-ingelheim.com
*********@sprintmail.com
Colleagues
Vice President, Financial Planning & Analysis
Vice President of Sales
SVP Research and Development and Chief Medical Officer
Chief Accounting Officer
SVP, Chief Technical Officer
Member Board Of Directors
Board Member
SVP, Chief People Officer
Vice President, Clinical Development and Medical Affairs
Vice President, Supply Chain, Procurement and Sourcing